Table I.
Combination Index | |||
---|---|---|---|
Cell line | EGCG (µM) | Resveratrol (15 µl) | Resveratrol (20 µl) |
Tu212 | 30 | 0.93 | 0.73 |
35 | 0.68 | 0.63 | |
40 | 0.66 | 0.62 | |
45 | 0.62 | 0.68 | |
50 | 0.63 | 0.74 | |
55 | 0.61 | 0.43 | |
60 | 0.59 | 0.47 | |
SqCCy1 | 30 | 0.41 | 0.42 |
40 | 0.43 | 0.44 | |
50 | 0.43 | 0.43 | |
60 | 0.47 | 0.44 | |
70 | 0.49 | 0.43 | |
80 | 0.49 | 0.44 | |
MDA686TU | 30 | 0.49 | 0.46 |
40 | 0.47 | 0.46 | |
50 | 0.48 | 0.46 | |
60 | 0.43 | 0.44 | |
70 | 0.41 | 0.43 | |
80 | 0.41 | 0.45 |
Tu212, SqCCy1 and MDA686TU cells were treated with the indicated doses of EGCG, resveratrol and their combination and apoptosis was assessed after 72 h. Combination index values were calculated using CalcuSyn software. EGCG, epigallocatechin gallate.